Drugs / Albumin
Albumin
also known as
Human Albumin · human serum albumin · HSA · Albuman · Albumin 5% inj · Human Albumin Grifols 200 g/l, solution for infusion
Trials 64 · started per year
today
1
1
1
1
1
3
2
1
2
4
2
8
1
5
5
7
2
8
2
4
3
200220032004200520062007200820092010201120122013201420152016201720182019202020212022202320242025202620272028
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 13 trials | ||||||
| Phase 1 | NCT06172387 | Nov 2023 → Dec 2024 | ischemic stroke | Tianjin Huanhu Hospital | Unknown | No outcome recorded |
| Phase 1 | NCT05953623 | Aug 2023 → Jun 2024 | cerebral artery occlusion, ischemic stroke | Tianjin Huanhu Hospital | Completed | No outcome recorded |
| Phase 1 | NCT02716597 | Mar 2016 → Jan 2019 | — | Alexander Flannery, 859-323-4011 | Terminated | No outcome recorded Stop: Enrollment |
| Phase 1/21 trial | ||||||
| Phase 1/2 | NCT00228657 | Jul 2002 → Aug 2003 | decubitus ulcer | Bayside Health | Completed | No outcome recorded |
| Phase 212 trials · 1 met primary · 1 missed | ||||||
| Phase 2 | NCT07415655 | Feb 2026 → Feb 2027 expected | ischemic stroke | University Hospital Hradec Kralove | Recruiting | No outcome recorded |
| Phase 2 | NCT06538844 | Aug → Dec 2024 | ischemic stroke | Capital Medical University | Completed | Met primary |
| Phase 2 | NCT03941405 | Feb 2020 → Dec 2024 | cirrhosis of liver | Fundacion Clinic per a la Recerca Biomédica | Completed | No outcome recorded |
| Phase 2 | NCT05867602 | Mar 2019 → Mar 2027 expected | — | Baylor College of Medicine | Recruiting | No outcome recorded |
| Phase 2 | NCT03585257 | Jun 2018 → Feb 2022 | cirrhosis of liver, hepatic encephalopathy | Hunter Holmes Mcguire Veteran Affairs Medical Center | Completed | No outcome recorded |
| Phase 2 | NCT01587222 | Jul 2016 → Jul 2017 | hepatorenal syndrome, kidney failure | Anna Cruceta | Withdrawn | No outcome recorded |
| Phase 2 | NCT02479802 | Nov 2014 → Jun 2016 | amyotrophic lateral sclerosis | Grifols | Completed | No outcome recorded |
| Phase 2 | NCT01133795 | Feb 2010 → Jun 2016 | cirrhosis of liver, kidney failure | Hospital Clinic of Barcelona | Completed | No outcome recorded |
| Phase 2 | NCT00990509 | Sep 2009 → Jun 2013 | intracerebral hemorrhage | Georgetown University | Terminated | No outcome recorded Stop: Enrollment |
| Phase 2 | NCT00819416 | Feb → Oct 2009 | infectious disease with sepsis | Ottawa Hospital Research Institute | Completed | No outcome recorded |
| Phase 2 | NCT00428506 | Feb 2007 → Dec 2008 | — | University of Turin, Italy | Unknown | Missed primary |
| Phase 2 | NCT00852800 | Mar 2006 → Aug 2009 | impaired renal function disease | Hospital de Clinicas de Porto Alegre | Unknown | No outcome recorded |
| Phase 2/33 trials | ||||||
| Phase 2/3 | NCT06224777 | Jan → Dec 2022 | — | King Edward Medical University | Completed | No outcome recorded |
| Phase 2/3 | NCT04303416 | Mar 2020 → Feb 2021 | adrenomyeloneuropathy | Pujol, Aurora, M.D. | Completed | No outcome recorded |
| Phase 2/3 | NCT00240045 | Oct 2005 → Jul 2007 | hepatorenal syndrome | University of Alberta | Completed | No outcome recorded |
| Phase 310 trials · 1 met primary · 1 missed | ||||||
| Phase 3 | NCT07597135 | Jun 2026 → Sep 2028 expected | tooth disorder | ahmed mostafa ahmed abo el soud | Not yet recruiting | No outcome recorded |
| Phase 3 | NCT07395141 | Mar → May 2026 overdue | cirrhosis of liver, esophageal varices with bleeding | King George's Medical University | Not yet recruiting | No outcome recorded |
| Phase 3 | NCT07263308 | Dec 2025 → Jun 2027 expected | ischemic stroke | Capital Medical University | Recruiting | No outcome recorded |
| Phase 3 | NCT07072572 | Mar → Dec 2023 | acute kidney injury, cirrhosis of liver | Centro Medico Issemym | Completed | No outcome recorded |
| Phase 3 | NCT03702920 | Jun 2019 → Apr 2025 | liver disorder | Grifols | Terminated | Met primary Stop: Business |
| Phase 3 | NCT03654001 | May 2019 → Oct 2024 | infectious disease with sepsis | Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico | Completed | No outcome recorded |
| Phase 3 | NCT03974074 | Mar 2019 → Dec 2020 | hepatocellular carcinoma, plasma protein metabolism disease | Guangxi Medical University | Unknown | No outcome recorded |
| Phase 3 | NCT03451292 | Jul 2018 → May 2024 | — | Grifols Therapeutics LLC | Completed | Missed primary |
| Phase 3 | NCT04076254 | Oct 2016 → Sep 2019 | Dengue hemorrhagic fever | Indonesia University | Unknown | No outcome recorded |
| Phase 3 | NCT02055872 | Sep 2014 → Oct 2016 | plasma protein metabolism disease | Hamilton Health Sciences Corporation | Completed | No outcome recorded |
| Phase 416 trials · 3 missed | ||||||
| Phase 4 | NCT06667999 | Jun 2025 → Dec 2035 expected | — | Anders Perner | Recruiting | No outcome recorded |
| Phase 4 | NCT05726136 | Oct 2023 → Oct 2026 expected | benign neoplasm, colorectal cancer, female reproductive organ cancer, malignant urinary system neoplasm | Joachim Zdolsek | Recruiting | No outcome recorded |
| Phase 4 | NCT05391607 | May 2022 → Mar 2023 | — | Insel Gruppe AG, University Hospital Bern | Completed | No outcome recorded |
| Phase 4 | NCT05441878 | Aug 2020 → Oct 2023 | cirrhosis of liver | Post Graduate Institute of Medical Education and Research, Chandigarh | Unknown | No outcome recorded |
| Phase 4 | NCT04184401 | Jan 2020 → Nov 2021 | — | Seoul National University Hospital | Completed | No outcome recorded |
| Phase 4 | NCT03848507 | Mar 2019 → Feb 2020 | — | Insel Gruppe AG, University Hospital Bern | Completed | No outcome recorded |
| Phase 4 | NCT03699462 | Nov 2018 → Oct 2020 | coronary artery disorder | Yonsei University | Completed | Missed primary |
| Phase 4 | NCT03453320 | Feb 2018 → Jan 2019 | — | University Hospital, Linkoeping | Completed | No outcome recorded |
| Phase 4 | NCT02560519 | Mar 2017 → Apr 2020 | — | Helsinki University Central Hospital | Completed | Missed primary |
| Phase 4 | NCT02952378 | Oct 2016 → Jan 2019 | — | University Hospital, Linkoeping | Completed | No outcome recorded |
| Phase 4 | NCT03153306 | Jun 2016 → Dec 2017 | infectious disease with sepsis | Hainan People's Hospital | Unknown | No outcome recorded |
| Phase 4 | NCT02556580 | Feb 2016 → Dec 2018 | — | Sodertalje Hospital | Unknown | No outcome recorded |
| Phase 4 | NCT02034279 | May 2014 → Dec 2016 | bacterial infectious disease, cholangitis, liver disorder, pneumonia +1 | EASL - CLIF Consortium | Terminated | Missed primary Stop: Enrollment |
| Phase 4 | NCT01763853 | Dec 2012 → Apr 2017 | acute respiratory distress syndrome, pulmonary edema | University Hospital, Clermont-Ferrand | Unknown | No outcome recorded |
| Phase 4 | NCT01328132 | Mar → Oct 2011 | disease related to solid organ transplantation | McGill University Health Centre/Research Institute of the McGill University Health Centre | Unknown | No outcome recorded |
| Phase 4 | NCT00968695 | Jul 2009 → Apr 2014 | cirrhosis of liver | Grifols | Completed | No outcome recorded |
| Phase not applicable19 trials · 1 met primary · 1 missed | ||||||
| — | NCT07417969 | Jun 2025 → Sep 2026 overdue | anuria | Jose J Zaragoza, MD MSc | Recruiting | No outcome recorded |
| — | NCT06809088 | Jan 2025 → Jan 2026 overdue | acute kidney injury, cirrhosis of liver | Institute of Liver and Biliary Sciences, India | Not yet recruiting | No outcome recorded |
| — | NCT06245590 | Feb 2024 → Jan 2025 | cirrhosis of liver | Institute of Liver and Biliary Sciences, India | Unknown | No outcome recorded |
| — | NCT06091345 | Dec 2023 → Dec 2025 | cirrhosis of liver | Institute of Liver and Biliary Sciences, India | Completed | No outcome recorded |
| — | NCT06026267 | Oct 2023 → Dec 2024 overdue | cirrhosis of liver, infectious peritonitis | Institute of Liver and Biliary Sciences, India | Recruiting | No outcome recorded |
| — | NCT06076330 | Sep 2023 → Aug 2024 | cirrhosis of liver | Institute of Liver and Biliary Sciences, India | Unknown | No outcome recorded |
| — | NCT05937048 | Jul 2023 → Nov 2024 | cirrhosis of liver | Institute of Liver and Biliary Sciences, India | Completed | No outcome recorded |
| — | NCT04679571 | Dec 2020 → Sep 2022 | cirrhosis of liver | Institute of Liver and Biliary Sciences, India | Unknown | No outcome recorded |
| — | NCT04437810 | Jul 2020 → Apr 2022 | acute kidney injury, cirrhosis of liver | Institute of Liver and Biliary Sciences, India | Unknown | No outcome recorded |
| — | NCT04273373 | Mar → Dec 2020 | infectious peritonitis | Institute of Liver and Biliary Sciences, India | Completed | No outcome recorded |
| — | NCT03754400 | Sep 2018 → Jul 2020 | liver failure | Institute of Liver and Biliary Sciences, India | Unknown | No outcome recorded |
| — | NCT02721238 | Dec 2016 → Nov 2018 | cirrhosis of liver | Institute of Liver and Biliary Sciences, India | Completed | Met primary |
| — | NCT02765009 | Jun 2016 → Jul 2019 | — | Central Hospital, Nancy, France | Completed | Missed primary |
| — | NCT02467348 | Mar 2015 → Jan 2017 | liver failure | Institute of Liver and Biliary Sciences, India | Completed | No outcome recorded |
| — | NCT02467322 | Feb 2015 → Dec 2016 | cirrhosis of liver | Institute of Liver and Biliary Sciences, India | Completed | No outcome recorded |
| — | NCT02462902 | Feb 2014 → Jun 2015 | cirrhosis of liver | Institute of Liver and Biliary Sciences, India | Completed | No outcome recorded |
| — | NCT01932151 | Dec 2012 → Jul 2013 | hepatorenal syndrome | Hospital Clinic of Barcelona | Completed | No outcome recorded |
| — | NCT00842803 | Jan 2010 → Jun 2012 | — | McGill University Health Centre/Research Institute of the McGill University Health Centre | Unknown | No outcome recorded |
| — | NCT00978588 | Feb → Dec 2008 | mitral valve disorder | Yonsei University | Completed | No outcome recorded |
| Comparator or background therapy57 trials | ||||||
| Phase 1 | NCT05080543 Comparator | Oct 2021 → Sep 2022 | infectious disease with sepsis | Amany Mousa Salama Muhammed | Unknown | No outcome recorded |
| Phase 1/2 | NCT03919773 Comparator | Oct 2018 → Jun 2023 | postural orthostatic tachycardia syndrome | University of Texas Southwestern Medical Center | Completed | No outcome recorded |
| Phase 2 | NCT06812390 Comparator | Feb 2025 → Dec 2026 expected | cirrhosis of liver | Anahita Rabiee MD MHS | Recruiting | No outcome recorded |
| Phase 2 | NCT06052176 Comparator | Nov 2023 → Oct 2026 expected | cirrhosis of liver, hepatic encephalopathy | Hunter Holmes Mcguire Veteran Affairs Medical Center | Recruiting | No outcome recorded |
| Phase 2 | NCT04048707 Background | Jul 2021 → Jun 2023 | acute kidney injury, cirrhosis of liver, hepatorenal syndrome | University of California, Los Angeles | Withdrawn | No outcome recorded Stop: Business |
| Phase 2 | NCT04109144 Comparator | Nov 2019 → Jul 2023 | cirrhosis of liver | Montefiore Medical Center | Withdrawn | No outcome recorded Stop: Enrollment |
| Phase 2 | NCT03665311 Comparator | Mar 2019 → Jan 2020 | acute kidney injury, hypotensive disorder | Ottawa Hospital Research Institute | Completed | No outcome recorded |
| Phase 2/3 | NCT03420144 Comparator | Jan 2018 → Jun 2020 | cirrhosis of liver | Post Graduate Institute of Medical Education and Research, Chandigarh | Completed | No outcome recorded |
| Phase 2/3 | NCT03415698 Comparator | Jul 2016 → Jul 2018 | cirrhosis of liver | Post Graduate Institute of Medical Education and Research, Chandigarh | Unknown | No outcome recorded |
| Phase 2/3 | NCT00742690 Comparator | May 2005 → Dec 2014 | cirrhosis of liver, hepatorenal syndrome | University of Padova | Unknown | No outcome recorded |
| Phase 2/3 | NCT00742339 Comparator | May 2005 → Oct 2013 | cirrhosis of liver, hepatorenal syndrome | University of Padova | Terminated | No outcome recorded |
| Phase 3 | NCT07139392 Comparator | Sep 2025 overdue | — | shaimaa hamdy | Not yet recruiting | No outcome recorded |
| Phase 3 | NCT06113848 Comparator | Sep 2023 → Sep 2024 | ischemic stroke | Tianjin Huanhu Hospital | Unknown | No outcome recorded |
| Phase 3 | NCT04621617 Comparator | Nov 2020 → Dec 2021 | — | Post Graduate Institute of Medical Education and Research, Chandigarh | Unknown | No outcome recorded |
| Phase 3 | NCT01337934 Comparator | Oct 2013 → Oct 2016 | infectious disease with sepsis | University of Sao Paulo | Completed | No outcome recorded |
| Phase 3 | NCT00986817 Background | Nov 2009 → Mar 2015 | cirrhosis of liver | Assistance Publique - Hôpitaux de Paris | Completed | No outcome recorded |
| Phase 3 | NCT01758172 Comparator | Oct 2009 → Oct 2010 | — | Asan Medical Center | Completed | No outcome recorded |
| Phase 3 | NCT00235495 Comparator | Jun 2006 → Feb 2013 | ischemic stroke | University of Miami | Terminated | No outcome recorded Stop: Enrollment |
| Phase 4 | NCT06892535 Comparator | Feb 2024 → Feb 2025 | hepatic vascular disorder | Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh | Completed | No outcome recorded |
| Phase 4 | NCT04705896 Comparator | Nov 2023 → Aug 2025 overdue | acute kidney injury, hypotensive disorder | Ottawa Hospital Research Institute | Recruiting | No outcome recorded |
| Phase 4 | NCT05463471 Comparator | Aug 2022 → Dec 2025 overdue | — | Peking Union Medical College Hospital | Not yet recruiting | No outcome recorded |
| Phase 4 | NCT05148286 Comparator | Jan 2022 → Sep 2027 expected | infectious disease with sepsis | Asan Medical Center | Recruiting | No outcome recorded |
| Phase 4 | NCT03202524 Comparator | Dec 2017 → Jul 2018 | cirrhosis of liver | Montefiore Medical Center | Withdrawn | No outcome recorded |
| Phase 4 | NCT04522635 Comparator | Jun 2015 → Dec 2017 | hypotensive disorder | University of California, San Diego | Completed | No outcome recorded |
| Phase 4 | NCT02738190 Comparator | Jan 2015 → May 2016 | hemorrhagic disease | IRCCS Policlinico S. Donato | Completed | No outcome recorded |
| Phase 4 | NCT02728921 Comparator | Apr 2014 → Oct 2016 | pancreatic neoplasm | Region Skane | Completed | No outcome recorded |
| Phase 4 | NCT01559519 Comparator | Sep 2012 → Dec 2013 | hepatic encephalopathy | University of Roma La Sapienza | Completed | No outcome recorded |
| Phase 4 | NCT01530711 Background | Apr 2012 → Dec 2016 | cirrhosis of liver, hepatorenal syndrome | Pere Gines | Unknown | No outcome recorded |
| Phase 4 | NCT00936247 Comparator | Nov 2009 → Sep 2010 | impaired renal function disease | B. Braun Melsungen AG | Terminated | No outcome recorded Stop: Enrollment |
| Phase 4 | NCT00886925 Comparator | Mar 2009 → Jul 2012 | hepatic encephalopathy | Hospital Universitari Vall d'Hebron Research Institute | Completed | No outcome recorded |
| Phase 4 | NCT00839358 Comparator | Aug 2008 → Feb 2016 | hepatic encephalopathy, infectious disease with sepsis, kidney failure | Hospital Clinic of Barcelona | Completed | No outcome recorded |
| Phase 4 | NCT00327704 Comparator | Jul 2006 → Jun 2010 | infectious disease with sepsis | LFB | Completed | No outcome recorded |
| Phase 4 | NCT00308100 Comparator | Oct 2005 → Jul 2008 | — | Fresenius Kabi | Terminated | No outcome recorded Stop: Enrollment |
| Phase 4 | NCT00761098 Comparator | May 2005 → May 2010 | cirrhosis of liver, infectious peritonitis | Weill Medical College of Cornell University | Unknown | No outcome recorded |
| Phase 4 | NCT00108355 Comparator | Dec 2003 → Aug 2010 | cirrhosis of liver | US Department of Veterans Affairs | Completed | No outcome recorded |
| Phase 4 | NCT00708747 Comparator | Jul 1996 → Jun 2001 | autoinflammatory syndrome | Medical University of Vienna | Completed | No outcome recorded |
| — | NCT07002827 Background | Jun 2025 → Dec 2026 expected | cirrhosis of liver | Institute of Liver and Biliary Sciences, India | Recruiting | No outcome recorded |
| — | NCT06654687 Comparator | Oct 2024 → Feb 2025 | pregnancy disorder | Sameh Fathy | Completed | No outcome recorded |
| — | NCT05346393 Comparator | Nov 2022 → Jun 2025 overdue | acute kidney injury, cirrhosis of liver, hepatorenal syndrome | Jena University Hospital | Recruiting | No outcome recorded |
| — | NCT05287100 Background | Jan 2022 → May 2023 | cirrhosis of liver | Institute of Liver and Biliary Sciences, India | Completed | No outcome recorded |
| — | NCT04816240 Background | May 2021 → Mar 2022 | cirrhosis of liver | Institute of Liver and Biliary Sciences, India | Unknown | No outcome recorded |
| — | NCT04474262 Background | Jul 2020 → Mar 2021 | liver disorder | Institute of Liver and Biliary Sciences, India | Unknown | No outcome recorded |
| — | NCT04416282 Background | Jun 2020 → Jun 2022 | acute kidney injury, hepatorenal syndrome | Institute of Liver and Biliary Sciences, India | Completed | No outcome recorded |
| — | NCT04013113 Background | Jul 2019 → Jul 2020 | liver disorder | Institute of Liver and Biliary Sciences, India | Unknown | No outcome recorded |
| — | NCT03645642 Background | Sep → Dec 2018 | hepatobiliary disorder | Institute of Liver and Biliary Sciences, India | Completed | No outcome recorded |
| — | NCT03306914 Comparator | Oct 2017 → Feb 2019 | — | Cairo University | Completed | No outcome recorded |
| — | NCT03144713 Comparator | May 2017 → Apr 2018 | cirrhosis of liver | Institute of Liver and Biliary Sciences, India | Completed | No outcome recorded |
| — | NCT02811406 Comparator | Jun 2016 → Jun 2017 | hypotensive disorder | National University Hospital, Singapore | Unknown | No outcome recorded |
| — | NCT02788240 Background | May 2016 → Jul 2017 | liver failure | Institute of Liver and Biliary Sciences, India | Terminated | No outcome recorded |
| — | NCT02573727 Background | Oct 2015 → Jan 2017 | liver failure | Institute of Liver and Biliary Sciences, India | Completed | No outcome recorded |
| — | NCT03547895 Comparator | Jun 2015 → May 2016 | cirrhosis of liver | Zagazig University | Completed | No outcome recorded |
| — | NCT02468089 Background | May 2015 → Aug 2017 | infectious peritonitis | Institute of Liver and Biliary Sciences, India | Completed | No outcome recorded |
| — | NCT02782819 Comparator | Sep 2014 → Aug 2018 | hypotensive disorder | Mahidol University | Unknown | No outcome recorded |
| — | NCT02123576 Background | Apr 2014 → Dec 2017 | hepatorenal syndrome | Patrick Northup, MD | Terminated | No outcome recorded Stop: Enrollment |
| — | NCT02756741 Comparator | Apr 2014 → Jul 2015 | cirrhosis of liver | All India Institute of Medical Sciences | Completed | No outcome recorded |
| — | NCT01852630 Background | Dec 2012 → Dec 2015 | infectious peritonitis | Institute of Liver and Biliary Sciences, India | Completed | No outcome recorded |
| — | NCT02528097 Comparator | Sep 2010 → Jan 2015 | infectious peritonitis | NYU Langone Health | Terminated | No outcome recorded |
News releases announcing trial results or a regulatory action · 3
| Date | Issuer | Release |
|---|---|---|
| 2024-12-20 | Grifols Therapeutics LLC | Results Grifols announces topline phase 3 data on long-term Albutein® (albumin [human] U.S.P.) therapy for decompensated cirrhosis with ascites grifols.com ↗
Further, a notable improvement in time-to-liver transplant or death at three months was observed for the study treatment plus SMT group of patients, when compared with the patients treated only with SMT. |
| 2020-07-27 | Grifols Therapeutics LLC | Results Results of Grifols’ AMBAR clinical trial published in Alzheimer's & Dementia: The Journal of the Alzheimer’s Association grifols.com ↗
The findings of the AMBAR clinical trial demonstrate a delay in the cognitive and functional decline in AD patients when their plasma is replaced with albumin and immunoglobulin (plasma-derived proteins) following the process of plasma extraction, using the plasmapheresis technique. |
| 2019-05-30 | BeOne Medicines | Regulatory BeiGene Announces Acceptance of Supplemental Import Drug Application in China for ABRAXANE® in Metastatic Pancreatic Cancer beonemedicines.com ↗ |
All press releases naming this drug 4 releases
| Date | Issuer | Release |
|---|---|---|
| 2024-12-20 | Grifols Therapeutics LLC | Grifols announces topline phase 3 data on long-term Albutein® (albumin [human] U.S.P.) therapy for decompensated cirrhosis with ascites grifols.com ↗ |
| 2023-07-18 | Grifols Therapeutics LLC | Grifols completes enrollment in phase 3 study of long-term Albutein® (albumin-human injection) therapy for patients with decompensated cirrhosis grifols.com ↗ |
| 2020-07-27 | Grifols Therapeutics LLC | Results of Grifols’ AMBAR clinical trial published in Alzheimer's & Dementia: The Journal of the Alzheimer’s Association grifols.com ↗ |
| 2019-05-30 | BeOne Medicines | BeiGene Announces Acceptance of Supplemental Import Drug Application in China for ABRAXANE® in Metastatic Pancreatic Cancer beonemedicines.com ↗ |
Evidence & citations 10 cited values
Every value below carries the sentence it was read from. 123 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Albumin | “We investigated the effect of albumin treatment (20% solution) on hypoalbuminemia, cardiocirculatory dysfunction, portal hypertension, and systemic inflammation in patients...” PMID 30905652 ↗ Mar 2019120“nutritional therapy ( high calorie intake- 2400 Kcal/ day) Lactulose, bowel wash, albumin, terlipressin, antibiotics and anti-virals in hepatitis B reactivation will be...” NCT04013113 ↗ “all patients receive albumin perfusion at the dose 8 g/l of removed ascites and Terlipressin (1mg) or placebo, administrated before and at the end of the paracentesis.” NCT00986817 ↗ “Standard Medical Therapy will include nutritional support, rifaximin, lactulose, bowel wash, albumin, diuretics, multivitamins and antibiotics as required” NCT03420144 ↗ “200cc of 20% human albumin with 15 cc per kg of crystalloid will be administered over 1\~2h for initial fluid resuscitation.” NCT05148286 ↗ “Nutritional support, rifaximin, lactulose, bowel wash, albumin, diuretics, multivitamins and antibiotics.” NCT03415698 ↗ “Albumin infusion 1g/kg/day - maximum 20gm/day and repeat till serum albumin reaches 2.8g/dl” NCT05287100 ↗ “Standard Care: 25% salt poor albumin administered day 1 (1.5g/kg) and day 3 (1.0g/kg)” NCT02528097 ↗ “Standard Care: 25% salt poor albumin administered day 1 (1.5g/kg) and day 3 (1.0g/kg)” NCT00761098 ↗ “The standard treatment of HRS-AKI is with the infusion of albumin and terlipressin.” NCT05346393 ↗ “Patient will receive 5% albumin or gelatin solution during shock resuscitation” NCT02782819 ↗ |
| Known as | Albuman | “Albuman® 200g/L (Sanquin, the Netherlands) is a solution containing 200 g/l (20%) of total protein of which at least 95% is human albumin.” NCT02560519 ↗ |
| Known as | Albumin 5% inj | “The group receiving receiving 5% albumin (Albumin 5% inj, Green cross, South Korea) during surgery” NCT03699462 ↗ |
| Known as | HSA | “Intra-arterial infusion of human serum albumin (HSA) may offer neuroprotective benefits; however, its safety and feasibility have not been established when delivered via the...” PMID 40921621 ↗ Sep 20251“In 2016, a study showed that in a rat model of normotensive endotoxemia, the infusion of 4% or 20% Human Serum Albumin "HSA" restored microvascular perfusion in otherwise...” NCT05080543 ↗ |
| Known as | Human Albumin | “Human Albumin In parallel with fluid administration for volume resuscitation, patients will receive 400 ml of 20% albumin solution both at randomization (D0) and at day 1 (D1).” NCT03654001 ↗3“human albumin, 25%, 2.0g/kg intravenously (or equivalent volume of saline control), infused over 2 h, commencing within 5 hours of stroke onset” NCT00235495 ↗ “Human Albumin 20% 1.5 g/kg body weight (Maximum 100g) on day 1 after the diagnosis, followed by 1 g/kg body weight (Maximum 100g)on day 3” NCT06026267 ↗ “Human albumin will be given intravenously at the dose of 1 g/kg of body weight on the first day followed by 20-40 g/day.” NCT00742690 ↗ |
| Known as | Human Albumin Grifols 200 g/l, solution for infusion | “Human Albumin Grifols 200 g/l, solution for infusion” NCT03941405 ↗ |
| Known as | human serum albumin | “Intra-arterial infusion of human serum albumin (HSA) may offer neuroprotective benefits; however, its safety and feasibility have not been established when delivered via the...” PMID 40921621 ↗ Sep 20252“In 2016, a study showed that in a rat model of normotensive endotoxemia, the infusion of 4% or 20% Human Serum Albumin "HSA" restored microvascular perfusion in otherwise...” NCT05080543 ↗ “Human serum albumin, at 2 g/kg, administered over 2 hours by intravenous infusion” NCT00235495 ↗ |
| Action | Restore | “albumin replacement in addition to crystalloids” PMID 24635772 ↗ Mar 2014 |
| Modality | Protein / enzyme biologic | “Biological: Albumin” NCT00235495 ↗ |
| Route | Intravenous | “Intravenous Albumin at a dose of 8g/liter of ascitic fluid removed” NCT00108355 ↗ |